You are here

BIOTEK, INC.

Company Information
Address
21-C OLYMPIA AVENUE
WOBURN, MA 01801
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. AN ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT

    Amount: $371,183.00

    THE OBJECTIVE OF THIS RESEARCH APPLICATION IS TO UTILIZE BIOTEK'S TRANSDERMAL DRUG DELIVERY SYSTEM FOR THE DEVELOPMENT OF A SUSTAINED TRANSDERMAL DELIVERY SYSTEM FOR ESTRADIOL AND LEVONORGESTREL FOR U ...

    SBIRPhase II1993Department of Health and Human Services
  2. DEVELOPMENT AND TESTING OF NEW SPERMICIDE SUPPOSITORY

    Amount: $359,057.00

    WE WILL EVALUATE THE DURATION OF EFFICACY OF A BIOERODIBLE CONTRACEPTIVE SPERMICIDE SUPPOSITORY IN ANIMALS. WE SEEK TO OPTIMIZE THE FORMULATION TO RELEASE SPERMICIDE OVER A PERIOD OF 12-16 HOURS IN TH ...

    SBIRPhase II1993Department of Health and Human Services
  3. PRODUCTION OF POLYCLONAL ANTIBODIES IN RABBITS

    Amount: $252,556.00

    CHOLINESTERASES ARE WIDELY DISTRIBUTED THROUGHOUT THE BODY. THEY HYDROLYZE ACETYLCHOLINE (ACH), A COMPOUND WHICH SERVES ALSO AS THE NEUROHUMORAL AGENT IN PERIPHERAL JUNCTION TRANSMISSION. CHOLINESTERA ...

    SBIRPhase II1993Department of Defense Army
  4. Development of a Naltrexone Microcapsule Injection

    Amount: $49,973.00

    N/A

    SBIRPhase I1993Department of Health and Human Services
  5. Injectable Microcapsule for Estrogen Replacement Therapy

    Amount: $49,984.00

    N/A

    SBIRPhase I1993Department of Health and Human Services
  6. DEVELOPMENT OF BIOPORE BIODEGRADABLE DELIVERY SYSTEM FOR BONE-INDUCTIVE PROTEINS AND GROWTH FACTORS

    Amount: $49,974.00

    CRANIOFACIAL INJURIES, EITHER CONGENITAL OR ACQUIRED, ARE A MAJOR CAUSE OF DISFIGUREMENT AND LOSS OF FUNCTION. THEY ACCOUNT FOR A SIGNIFICANT FRACTION OF WARTIME CASUALTIES AND OF CIVILIAN INJURIES FR ...

    SBIRPhase I1992Department of Defense Army
  7. TRANSDERMAL TERBUTALINE FOR THE TREATMENT OF ASTHMA

    Amount: $49,993.00

    ASTHMA IS A COSTLY AND WIDESPREAD BREATHING DISORDER PRONE TO STRIKE CHILDREN. ADVANCES IN TREATMENT HAVE LED TO BETA-2 ADRENERGIC DRUGS, SUCH AS TERBUTALINE HEMISULFATE (TBS), WHICH PROVIDE RELIEF WI ...

    SBIRPhase I1992Department of Health and Human Services
  8. IMPROVED DOSED DELIVERY OF HORMONES

    Amount: $49,976.00

    A RAPIDLY INCREASING NUMBER OF HORMONES AND BIOACTIVE PEPTIDES ARE BECOMING AVAILABLE TO MEDICAL RESEARCHERS. THESE DRUGS CANNOT BE ORALLY ADMINISTERED, SO IT IS IMPORTANT TO INVESTIGATE THEIR PHARMAC ...

    SBIRPhase I1992Department of Health and Human Services
  9. A 30-DAY SUSTAINED RELEASE INJECTION OF CLONAZEPAM

    Amount: $49,918.00

    EPILEPSY IS A FAMILY OF RECURRENT SEIZURE DISORDERS AFFLICTING 1-2 MILLION PEOPLE IN THE U.S. ALONE. ALTHOUGH THE ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM OF NINDS HAS EFFECTIVELY FOSTERED THE DEVELOPME ...

    SBIRPhase I1992Department of Health and Human Services
  10. N/A

    Amount: $49,997.00

    N/A

    SBIRPhase I1992Department of Health and Human Services
US Flag An Official Website of the United States Government